Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 563 |
| Receivables | 321 |
| TOTAL | $884 |
| Non-Current Assets | |
| PPE Net | 1 |
| TOTAL | $1 |
| Total Assets | $886 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 101 |
| Accrued Expenses | 72 |
| TOTAL | $172 |
| Non-Current Liabilities | |
| Long Term Debt | 857 |
| TOTAL | $857 |
| Total Liabilities | $1,030 |
| Shareholders' Equity | |
| Common Shares | 3,415 |
| Retained earnings | -3,753 |
| TOTAL | $-144 |
| Total Liabilities And Equity | $886 |